Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069742 · ClinicalTrials.gov registry record · NA
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
A NA study of Breast Neoplasm, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT03069742 is a NA study of Breast Neoplasm that has completed, run by Columbia University. The registered enrollment target is 300 participants, above the 151-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (99% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03069742, a NA study of Breast Neoplasm, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial (RCT) is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer prevention options. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigators hypothesize that improving accuracy of breast cancer risk perception and understanding of the risks and benefits of breast cancer risk lowering drugs, also known as chemoprevention, will increase the uptake of chemoprevention in the primary care setting.
Conditions Studied
Interventions
- OTHER RealRisks
- OTHER BNAV
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03069742
The ClinicalTrials.gov registry entry for NCT03069742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 151-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (99% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which RealRisks is the first listed.
NCT03069742 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03069742 about?
NCT03069742 is a clinical study titled "Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting". The purpose of this randomized controlled trial (RCT) is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer prevention options. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care set...
What is the current status of trial NCT03069742?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-11. Estimated completion is 2022-08.
What conditions does trial NCT03069742 study?
This clinical trial studies the following conditions: Breast Neoplasm.
What interventions are being tested in trial NCT03069742?
The interventions under investigation include: RealRisks (OTHER), BNAV (OTHER).
Who is sponsoring clinical trial NCT03069742?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03069742 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
RECRUITING · NA
-
Cryoablation vs Lumpectomy in T1 Breast Cancers
RECRUITING · NA
-
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
RECRUITING · NA
-
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
ACTIVE NOT RECRUITING · NA
-
Post-treatment Care of Breast Cancer Survivors
COMPLETED · NA
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.